Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies
In 2019, the novel coronavirus, SARS-CoV-2, caused a worldwide pandemic, affecting more than 630 million individuals and causing 6.5 million deaths. In the general population, poorer outcomes have been associated with older age, chronic lung and cardiovascular diseases, and lymphopenia, highlighting...
| Main Authors: | Tomas Milota, Jitka Smetanova, Jirina Bartunkova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-01-01
|
| Series: | Pathogens |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-0817/12/1/109 |
Similar Items
-
Development of Coronavirus Treatments Using Neutralizing Antibodies
by: Saman Fouladirad, et al.
Published: (2021-01-01) -
COVID‐19 in a child with primary antibody deficiency
by: Hamid Ahanchian, et al.
Published: (2021-02-01) -
Gastrointestinal Involvement in Primary Antibody Deficiencies
by: Tomas Milota, et al.
Published: (2023-01-01) -
Antibodies to SARS-Coronavirus in Civets
by: Changchun Tu, et al.
Published: (2004-12-01) -
Characteristics and Prognosis of Antibody Non-responders With Coronavirus Disease 2019
by: Junyu Ding, et al.
Published: (2022-06-01)